GlaxoSmithKline said its Chinese unit would pay a fine of about £300m after it was found guilty of bribing non-government personnel in the country following a long-running and high-profile investigation.
葛蘭素史克稱其中國機構因對非國家工作人員行賄已被判罰30億元人民幣，這一有罪判決是在經歷了長時間的高級別調查後作出的。
您已閱讀11%（262字），剩餘89%（2061字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。